GCP
FENC icon

GSA Capital Partners’s Fennec Pharmaceuticals FENC Stock Holding History

GSA Capital Partners’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-68,724
Closed -$501K – 1547
2021
Q2 		$501K Buy
68,724
+32,251
+88% +$215K 0.06% 620
2021
Q1 		$226K Buy
+36,473
New +$275K 0.04% 823
2020
Q4 		– Sell
-22,385
Closed -$136K – 1322
2020
Q3 		$136K Buy
+22,385
New +$158K 0.02% 1084

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSA Capital Partners's FENC Position: Q3 2021 in Review

GSA Capital Partners sold out of Fennec Pharmaceuticals (FENC) in Q3 2021, closing a stake of 68,724 shares — an estimated $501K sold.

GSA Capital Partners first reported a position in FENC in Q3 2020 and held it in 3 quarters. The position peaked at $501K in Q2 2021. 32 funds tracked by Wall St. Rank hold FENC as of Q3 2021.

  • GSA Capital Partners reported no remaining Fennec Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • GSA Capital Partners sold 68,724 Fennec Pharmaceuticals shares in Q3 2021, an estimated $501K.
  • GSA Capital Partners first reported a position in Fennec Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • GSA Capital Partners's Fennec Pharmaceuticals position peaked at $501K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.